期刊文献+

白细胞介素2的临床应用研究进展

暂未订购
导出
摘要 基因工程白细胞介素2(rIL-2)的问世推动了IL-2的临床应用研究。本文介绍了白细胞介素2(IL-2)的药物动力学与副作用、给药方式和临床应用、尤其是对肿瘤和免疫缺陷性疾病的效果。但是IL-2的临床应用尚属研究阶段,在广泛应用于临床之前,尚有很多问题有待解决。
作者 张学军 刘琏
出处 《国外医学(预防.诊断.治疗用生物制品分册)》 1989年第1期4-7,共4页 Foreign Medical Sciences(Section of Bilogics for Prophylaxis,Diagnosis and Therapy)
  • 相关文献

参考文献4

  • 1Stephen E. Ettinghausen,Steven A. Rosenberg. The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2[J] 1986,Springer Seminars in Immunopathology(1):51~71
  • 2Raoul R. Salup,Robert H. Wiltrout. Treatment of adenocarcinoma in the peritoneum of mice: Chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease[J] 1986,Cancer Immunology Immunotherapy(1):31~36
  • 3Kenichi Shiiba,Ryuji Suzuki,Kazutake Kawakami,Akio Ohuchi,Katsuo Kumagai. Interleukin 2-activated killer cells: generation in collaboration with interferonγ and its suppression in cancer patients[J] 1986,Cancer Immunology Immunotherapy(2):119~128
  • 4Takashi Nishimura,Yuji Togashi,Makiko Goto,Hideki Yagi,Yasushi Uchiyama,Yoshiyuki Hashimoto. Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2[J] 1986,Cancer Immunology Immunotherapy(1):12~18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部